BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26041540)

  • 1. CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28-CD8+ T Cells.
    Leitner J; Herndler-Brandstetter D; Zlabinger GJ; Grubeck-Loebenstein B; Steinberger P
    J Immunol; 2015 Jul; 195(2):477-87. PubMed ID: 26041540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
    J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD2/CD28 chimeric receptor triggers the CD28 signaling pathway in CTLL.2 cells.
    Feldhaus AL; Evans L; Sutherland RA; Jones LA
    Gene Ther; 1997 Aug; 4(8):833-8. PubMed ID: 9338012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of B7-1 and LFA-3 in costimulation of CD8+ T cells.
    Parra E; Wingren AG; Hedlund G; Kalland T; Dohlsten M
    J Immunol; 1997 Jan; 158(2):637-42. PubMed ID: 8992978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules.
    Costello R; Brailly H; Mallet F; Mawas C; Olive D
    Immunology; 1993 Nov; 80(3):451-7. PubMed ID: 7904590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes.
    Damle NK; Klussman K; Linsley PS; Aruffo A
    J Immunol; 1992 Apr; 148(7):1985-92. PubMed ID: 1372018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
    Watson CL; Furlong SJ; Hoskin DW
    Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones.
    Weekes MP; Carmichael AJ; Wills MR; Mynard K; Sissons JG
    J Immunol; 1999 Jun; 162(12):7569-77. PubMed ID: 10358214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
    Hirokawa M; Gray JD; Takahashi T; Horwitz DA
    J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo.
    Dolfi DV; Duttagupta PA; Boesteanu AC; Mueller YM; Oliai CH; Borowski AB; Katsikis PD
    J Immunol; 2011 Apr; 186(8):4599-608. PubMed ID: 21389258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postthymic development of CD28-CD8+ T cell subset: age-associated expansion and shift from memory to naive phenotype.
    Nociari MM; Telford W; Russo C
    J Immunol; 1999 Mar; 162(6):3327-35. PubMed ID: 10092786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.
    Young JW; Koulova L; Soergel SA; Clark EA; Steinman RM; Dupont B
    J Clin Invest; 1992 Jul; 90(1):229-37. PubMed ID: 1378854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulatory signals potently modulate the T cell inhibitory capacity of the therapeutic CD11a antibody Efalizumab.
    Kuschei WM; Leitner J; Majdic O; Pickl WF; Zlabinger GJ; Grabmeier-Pfistershammer K; Steinberger P
    Clin Immunol; 2011 May; 139(2):199-207. PubMed ID: 21414849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priming of CD8 T cells by adenoviral vectors is critically dependent on B7 and dendritic cells but only partially dependent on CD28 ligation on CD8 T cells.
    Nielsen KN; Steffensen MA; Christensen JP; Thomsen AR
    J Immunol; 2014 Aug; 193(3):1223-32. PubMed ID: 24951814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Src tyrosine kinase Lck binds to CD2, CD4-1, and CD4-2 T cell co-receptors in channel catfish, Ictalurus punctatus.
    Taylor EB; Wilson M; Bengten E
    Mol Immunol; 2015 Aug; 66(2):126-38. PubMed ID: 25771179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes.
    Tan R; Teh SJ; Ledbetter JA; Linsley PS; Teh HS
    J Immunol; 1992 Nov; 149(10):3217-24. PubMed ID: 1385518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
    de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
    Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.